These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33838133)
1. Upregulation of histone acetylation reverses organic anion transporter 2 repression and enhances 5-fluorouracil sensitivity in hepatocellular carcinoma. Wang Y; Zhu Q; Hu H; Zhu H; Yang B; He Q; Yu L; Zeng S Biochem Pharmacol; 2021 Jun; 188():114546. PubMed ID: 33838133 [TBL] [Abstract][Full Text] [Related]
2. SND1 Regulates Organic Anion Transporter 2 Protein Expression and Sensitivity of Hepatocellular Carcinoma Cells to 5-Fluorouracil. Wang Y; Wang Y; Fang Y; Jiang H; Yu L; Hu H; Zeng S Drug Metab Dispos; 2024 Aug; 52(9):997-1008. PubMed ID: 38960734 [TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma. Yang H; Lan P; Hou Z; Guan Y; Zhang J; Xu W; Tian Z; Zhang C Br J Cancer; 2015 Jan; 112(1):112-21. PubMed ID: 25393367 [TBL] [Abstract][Full Text] [Related]
4. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells. Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU. Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168 [TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells. Chan DW; Lee JM; Chan PC; Ng IO Int J Cancer; 2008 Sep; 123(5):1043-52. PubMed ID: 18553387 [TBL] [Abstract][Full Text] [Related]
7. Novel SAHA analogues inhibit HDACs, induce apoptosis and modulate the expression of microRNAs in hepatocellular carcinoma. Srinivas C; Swathi V; Priyanka C; Anjana Devi T; Subba Reddy BV; Janaki Ramaiah M; Bhadra U; Bhadra MP Apoptosis; 2016 Nov; 21(11):1249-1264. PubMed ID: 27502208 [TBL] [Abstract][Full Text] [Related]
8. Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression. Yang J; Jin X; Yan Y; Shao Y; Pan Y; Roberts LR; Zhang J; Huang H; Jiang J Sci Rep; 2017 Mar; 7():43864. PubMed ID: 28262837 [TBL] [Abstract][Full Text] [Related]
9. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma. Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975 [TBL] [Abstract][Full Text] [Related]
10. Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line. Gu W; Fang FF; Li B; Cheng BB; Ling CQ Asian Pac J Cancer Prev; 2012; 13(9):4807-14. PubMed ID: 23167424 [TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor quisinostat activates caspase signaling and upregulates p53 acetylation to inhibit the proliferation of HepG2 cells. Li F; Wang T; Wang Z; Chen X; Liu R Mol Med Rep; 2017 Nov; 16(5):6094-6101. PubMed ID: 28849080 [TBL] [Abstract][Full Text] [Related]
12. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells. Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051 [TBL] [Abstract][Full Text] [Related]
13. The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells. Ocker M; Alajati A; Ganslmayer M; Zopf S; Lüders M; Neureiter D; Hahn EG; Schuppan D; Herold C J Cancer Res Clin Oncol; 2005 Jun; 131(6):385-94. PubMed ID: 15754201 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound. Hu Z; Lv G; Li Y; Li E; Li H; Zhou Q; Yang B; Cao W J Exp Clin Cancer Res; 2016 Apr; 35():71. PubMed ID: 27102814 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21 Zhou H; Cai Y; Liu D; Li M; Sha Y; Zhang W; Wang K; Gong J; Tang N; Huang A; Xia J Cell Prolif; 2018 Jun; 51(3):e12447. PubMed ID: 29484736 [TBL] [Abstract][Full Text] [Related]
16. Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells. Li JY; Tian T; Han B; Yang T; Guo YX; Wu JY; Chen YS; Yang Q; Xie RJ World J Gastroenterol; 2023 Sep; 29(34):5038-5053. PubMed ID: 37753370 [TBL] [Abstract][Full Text] [Related]
17. Opsin3 sensitizes hepatocellular carcinoma cells to 5-fluorouracil treatment by regulating the apoptotic pathway. Jiao J; Hong S; Zhang J; Ma L; Sun Y; Zhang D; Shen B; Zhu C Cancer Lett; 2012 Jul; 320(1):96-103. PubMed ID: 22313545 [TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma. Wen X; Ling S; Wu W; Shan Q; Liu P; Wang C; Wei X; Ding W; Teng X; Xu X Dig Dis Sci; 2020 Apr; 65(4):1064-1073. PubMed ID: 31587155 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of histone deacetylase 7 reverses concentrative nucleoside transporter 2 repression in colorectal cancer by up-regulating histone acetylation state. Ye C; Han K; Lei J; Zeng K; Zeng S; Ju H; Yu L Br J Pharmacol; 2018 Nov; 175(22):4209-4217. PubMed ID: 30076612 [TBL] [Abstract][Full Text] [Related]
20. Identification of the genes chemosensitizing hepatocellular carcinoma cells to interferon-α/5-fluorouracil and their clinical significance. Sakabe T; Tsuchiya H; Kanki K; Azumi J; Gonda K; Mizuta Y; Yamada D; Wada H; Shomori K; Nagano H; Shiota G PLoS One; 2013; 8(2):e56197. PubMed ID: 23457527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]